BPC-157 vs GHK-Cu
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Body Protection Compound-157, Pentadecapeptide BPC 157
A synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.
Also: Copper Peptide, Glycyl-L-histidyl-L-lysine copper
A naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
Key Comparison Insights
- BPC-157 is categorized as Healing, while GHK-Cu is Skin & Hair.
- GHK-Cu has stronger research evidence (Human Trials) compared to BPC-157 (Animal Studies).
- These peptides are often used together in healing protocols for synergistic effects.
Detailed Comparison
| Attribute | BPC-157 | GHK-Cu |
|---|---|---|
| Category | Healing | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | BPC-157 modulates the nitric oxide system, promotes angiogenesis (new blood vessel formation), and upregulates growth hormone receptors. It also interacts with the dopaminergic system and has been shown to accelerate tendon-to-bone healing by promoting collagen synthesis. | GHK-Cu stimulates collagen and elastin synthesis, promotes glycosaminoglycan production, supports blood vessel growth, and has antioxidant and anti-inflammatory properties. It remodels damaged tissue and activates wound-healing genes. |
| Common Dosing | 250-500 mcg twice daily 1-2x daily | 1-2 mg daily (injection) or 0.05% topical Once daily |
| Administration | Subcutaneous injection near injury site, or systemic | Subcutaneous injection or topical application |
| Typical Duration | 4-12 weeks in most research protocols | Varies by application |
| Best Time to Take | Morning and evening (or near injury site timing) | Evening (for skin/recovery) |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract. 2025 AJSM systematic review: Of 544 articles screened, only 1 clinical study met inclusion criteria (rest were animal studies). Only 3 small human pilot studies exist (fewer than 30 total subjects). No pharmaceutical company has initiated FDA trials due to lack of patentability. FDA placed BPC-157 in Category 2 in September 2023. | 2023 double-blind split-face study (n=60) showed 22% increased skin firmness and 16% reduction in fine lines with 0.05% GHK-Cu serum. 2024 multicenter study found 25% faster epithelial recovery after laser resurfacing. 2025 research demonstrated anti-inflammatory effects in ulcerative colitis model via SIRT1/STAT3 pathway. Growing evidence for wound healing and anti-aging applications. |
Frequently Asked Questions: BPC-157 vs GHK-Cu
What is the difference between BPC-157 and GHK-Cu?
BPC-157 is a healing peptide that a synthetic peptide derived from a protein found in human gastric juice. known for its remarkable tissue healing properties across multiple body systems. fda classified as category 2 in 2023, restricting compounding. GHK-Cu is a skin & hair peptide that a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. widely used in skincare for its wound healing and anti-aging properties. The main differences lie in their mechanisms of action and clinical applications.
Which is better, BPC-157 or GHK-Cu?
Neither is universally "better" - the choice depends on your specific goals. BPC-157 is typically used for healing purposes, while GHK-Cu is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can BPC-157 and GHK-Cu be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using BPC-157 and GHK-Cu together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.